| SANOFI SA INHABER EO 2 | 76.53 / +0.66% |
| Date/Time | 03/03 / 09:00 |
| Chg. / Chg.(%) | 0.50 / +0.66% |
| Bid | 76.29 / 100 |
| Ask | 76.32 / 100 |
| Open | 76.50 |
| Previous Close | 76.03 |
| High | 76.53 |
| Low | 76.49 |
| Volume [EUR] | 0.00 |
| Volume [Units] | 0 |
| Price fixings | 3 |
| ISIN | FR0000120578 |
| Security | SNW |
| Exchange | Düsseldorf |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Euronext - P.. | 76.32 |  |
99,723 |
| Cboe Europe .. | 76.29 | |
27,884 |
| London Inter.. | 76.37 | |
11,569 |
| Turquoise | 76.37 | |
7,777 |
| TradeGate | 76.450 | |
627 |
| Frankfurt | 76.5100 | |
442 |
| Xetra | 76.45 | |
183 |
| Borsa Italia.. | 76.33 | |
100 |
| Hannover | 76.50 | |
25 |
| Vienna Globa.. | 76.53 | |
0 |
| Düsseldorf | 76.53 | |
0 |
| Hamburg | 76.50 | |
0 |
| Berlin | 76.43 | |
0 |
| München | 76.49 | |
0 |
| Lang & Schwa.. | 76.270 | |
|
| Stuttgart | 76.500 | |
|
| gettex | 76.320 | |
|
| Nasdaq Other.. | 91.3000 | |
2,501 |
| Cboe Europe .. | 76.41 | 3,093 | |
| Cboe Europe .. | 76.43 | 2,356 | |
| Borsa Italia.. | 78.20 |  |
3 |
| ICE Europe | Futures | ||
| EUREX | Options | ||
News
- Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress
03/02/2021 / 22:05 - GlobeNewswire - Kymera Therapeutics Announces First-in-Human Dose in Phase 1 Trial of KT-474, a First-in-Class IRAK4 Protein Degrader to Treat Immune-Inflammatory Diseases
03/02/2021 / 13:00 - GlobeNewswire - Translate Bio Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Progress
02/25/2021 / 22:05 - GlobeNewswire - FDA approves Libtayo® (cemiplimab-rwlc) monotherapy for patients with first-line advanced non-small cell lung cancer with PD-L1 expression of ≥50%
02/22/2021 / 19:00 - GlobeNewswire - GSK, Sanofi to restart 2nd phase COVID vaccine trial
02/22/2021 / 11:52 - TeleTrader
Real-time